A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ - PubMed (original) (raw)
. 1999 Jul 1;163(1):483-90.
Affiliations
- PMID: 10384152
A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ
C Ronsin et al. J Immunol. 1999.
Abstract
A number of Ags recognized by tumor-reactive T cells have been characterized, including nonmutated gene products and a variety of epitopes shown to arise from either mutated or alternatively processed transcripts. Here, we report that the screening of a cDNA library with an HLA-B7-restricted renal cell carcinoma-reactive T cell clone derived from tumor-infiltrating lymphocytes (TILs) that were clonally amplified in vivo (as assessed by TCRBV complementarity determining region-3 length distribution analysis) resulted in the isolation of a nonamer encoded by an alternative open reading frame (ORF) (a +1 frameshift) of the intestinal carboxyl esterase gene. This peptide binds HLA-B*0702-presenting molecules as assessed in an immunofluorescence-based peptide binding assay using transfected T2 cells. Constitutive expression of this alternative ORF protein was observed in all transformed HLA-B7+ renal cell lines that were recognized in cytotoxicity assays by the TILs. The intestinal carboxyl esterase gene is transcribed in renal cell carcinoma tumors as well as in normal liver, intestinal, or renal tissues. Mutation of the natural ATG translation initiation site did not alter recognition, indicating that frameshifting (i.e., slippage of the ribosome forward) and recoding are not involved. In addition, a point mutation of the three AUG codons that may be used as alternative translation initiation sites in the +1 ORF did not abolish recognition, whereas mutation of an upstream ACG codon did, indicating that the latter codon initiates the translation of the alternative ORF. These results further extend the types of Ags that can be recognized by tumor-reactive TILs in situ (i.e., leading to clonal T cell expansion).
Similar articles
- Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
Rimoldi D, Rubio-Godoy V, Dutoit V, Lienard D, Salvi S, Guillaume P, Speiser D, Stockert E, Spagnoli G, Servis C, Cerottini JC, Lejeune F, Romero P, Valmori D. Rimoldi D, et al. J Immunol. 2000 Dec 15;165(12):7253-61. doi: 10.4049/jimmunol.165.12.7253. J Immunol. 2000. PMID: 11120859 - An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes.
Probst-Kepper M, Stroobant V, Kridel R, Gaugler B, Landry C, Brasseur F, Cosyns JP, Weynand B, Boon T, Van Den Eynde BJ. Probst-Kepper M, et al. J Exp Med. 2001 May 21;193(10):1189-98. doi: 10.1084/jem.193.10.1189. J Exp Med. 2001. PMID: 11369790 Free PMC article. - A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
Gaudin C, Kremer F, Angevin E, Scott V, Triebel F. Gaudin C, et al. J Immunol. 1999 Feb 1;162(3):1730-8. J Immunol. 1999. PMID: 9973436 - Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen.
Mami-Chouaib F, Echchakir H, Dorothée G, Vergnon I, Chouaib S. Mami-Chouaib F, et al. Immunol Rev. 2002 Oct;188:114-21. doi: 10.1034/j.1600-065x.2002.18810.x. Immunol Rev. 2002. PMID: 12445285 Review. - TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes.
El Hage F, Durgeau A, Mami-Chouaib F. El Hage F, et al. Ann N Y Acad Sci. 2013 Apr;1283:75-80. doi: 10.1111/j.1749-6632.2012.06777.x. Epub 2013 Jan 9. Ann N Y Acad Sci. 2013. PMID: 23302073 Review.
Cited by
- Non-mutational neoantigens in disease.
Stern LJ, Clement C, Galluzzi L, Santambrogio L. Stern LJ, et al. Nat Immunol. 2024 Jan;25(1):29-40. doi: 10.1038/s41590-023-01664-1. Epub 2024 Jan 2. Nat Immunol. 2024. PMID: 38168954 Free PMC article. Review. - The landscape of T cell antigens for cancer immunotherapy.
Peri A, Salomon N, Wolf Y, Kreiter S, Diken M, Samuels Y. Peri A, et al. Nat Cancer. 2023 Jul;4(7):937-954. doi: 10.1038/s43018-023-00588-x. Epub 2023 Jul 6. Nat Cancer. 2023. PMID: 37415076 Review. - CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteins.
Othoum G, Maher CA. Othoum G, et al. NAR Cancer. 2023 Jun 1;5(2):zcad024. doi: 10.1093/narcan/zcad024. eCollection 2023 Jun. NAR Cancer. 2023. PMID: 37275273 Free PMC article. - Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review.
Kim TJ, Lee YH, Koo KC. Kim TJ, et al. Investig Clin Urol. 2022 Sep;63(5):486-498. doi: 10.4111/icu.20220103. Investig Clin Urol. 2022. PMID: 36067994 Free PMC article. Review. - Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.
Alarcon NO, Jaramillo M, Mansour HM, Sun B. Alarcon NO, et al. Pharmaceutics. 2022 Jul 11;14(7):1448. doi: 10.3390/pharmaceutics14071448. Pharmaceutics. 2022. PMID: 35890342 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials